<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Astellas Pharma 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=21351></link><description><![CDATA[Astellas Pharma 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 16 May 2026 10:43:19 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><language>ko-KR</language><item><title><![CDATA[Astellas, 백신 포트폴리오 구축 위해 ClearPath와 전략적 제휴관계 형성]]></title><link>https://www.newswire.co.kr/newsRead.php?no=731510</link><description><![CDATA[도쿄, 락빌, 에팔린제스--(뉴스와이어)--Astellas Pharma Inc. (Astellas)와 ClearPath Development Company (ClearPath)는 전염성 질환에 초점을 맞춘 개발 회사 포트폴리오 구성을 위한 전략적 제휴관계를 맺었다고 오늘 발표했다.   이 제휴관계는 Astellas가 글로벌 백신 프랜차이즈를 구축하려는 목표를 지원하기 위해 맺어졌으며 최초의 회사인 RSV Corporation (RSVC)를 2013년 12월에 출범시켰다. Astellas...]]></description><pubDate>Wed, 08 Jan 2014 10:56:46 +0900</pubDate></item><item><title><![CDATA[Astellas to Form Strategic Partnership With ClearPath To Build Vaccine Portfolio]]></title><link>https://www.newswire.co.kr/newsRead.php?no=731506</link><description><![CDATA[TOKYO, JAPAN and ROCKVILLE, MD and EPALINGES, SWIT--(Korea Newswire)--Astellas Pharma Inc. (Astellas) and ClearPath Development Company (ClearPath) announced today a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious diseases. The partnership was established to support Astellas‘ goal of building a global vaccine franchise and launched its first company, RSV ...]]></description><pubDate>Wed, 08 Jan 2014 10:51:31 +0900</pubDate></item></channel></rss>